Biomarin Pharmaceutical Inc. (NASDAQ:BMRN) stock Reported Profit Margin of 8.30 percent in Last Year: Is Defensible?
Robert W. Baird lowered the price target for the Biomarin Pharmaceutical Inc. (NASDAQ:BMRN) stock from “an Outperform” to “a Neutral”. The rating was released on May 17, 2024, according to finviz. The research report from Wells Fargo has initiated the stock to Overweight, with a price target set at $100. The stock was upgraded by […]
Morgan Stanley Assigned “an Equal-weight” Rating to ASE Technology Holding Co.Ltd ADR (NYSE:ASX) Stock
Morgan Stanley raised the price target for the ASE Technology Holding Co.Ltd ADR (NYSE:ASX) stock from “an Overweight” to “an Equal-weight”. The rating was released on June 25, 2024, according to finviz. We previously noted in another research note published on July 28, 2023 by Goldman that upgraded the stock from a Neutral to a […]
CNH Industrial NV (NYSE:CNH) stock is trading 3.99 percent above its 52-week low
Citigroup raised the price target for the CNH Industrial NV (NYSE:CNH) stock to “a Buy”. The rating was released on Jun-27-24, according to finviz. The research report from Truist has initiated the stock to Buy, with a price target set at $18. The stock was initiated by DA Davidson, who disclosed in a research note […]
PayPal Holdings Inc (NASDAQ:PYPL) Stock is trading Below -8.34% From 50-Day SMA
Goldman raised the price target for the PayPal Holdings Inc (NASDAQ:PYPL) stock to “a Neutral”. The rating was released on June 24, 2024, according to finviz. The research report from Mizuho has upgraded the stock from Neutral to Buy, with a price target set at $90. The stock was reiterated by Monness Crespi & Hardt, […]
United Therapeutics Corp (NASDAQ:UTHR) Stock higher 45.05% in This Year: What’s Happened?
Goldman raised the price target for the United Therapeutics Corp (NASDAQ:UTHR) stock from “a Sell” to “a Neutral”. The rating was released on February 12, 2024, according to finviz. The research report from Wells Fargo has initiated the stock to Overweight, with a price target set at $309. The stock was initiated by UBS, who […]
Why Boyd Gaming Corp. (NYSE:BYD) Stock fell -12.23% in Last Six Months?
Raymond James raised the price target for the Boyd Gaming Corp. (NYSE:BYD) stock to “an Outperform”. The rating was released on May 21, 2024, according to finviz. The research report from JP Morgan has downgraded the stock from Overweight to Neutral, with a price target set at $67. The stock was downgraded by Deutsche Bank, […]
Susquehanna raised the price target for the MGM Resorts International (NYSE:MGM) stock to “”a Positive””
Susquehanna raised the price target for the MGM Resorts International (NYSE:MGM) stock from “a Neutral” to “a Positive”. The rating was released on May 02, 2024, according to finviz. The research report from Mizuho has initiated the stock to Buy, with a price target set at $61. The stock was initiated by HSBC Securities, who […]
Tootsie Roll Industries, Inc. (NYSE:TR) stock Market Value Reached at $2.29 billion: What Happened?
The latest trade, Performances and Moving Averages give us the following Picture The firm’s stock price fluctuated 12.49% within the last five trades and 6.83% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 1.45% in the last 6 months […]
Why Royal Caribbean Group (NYSE:RCL) Stock climbed 17.92% in Last Three Months?
Mizuho raised the price target for the Royal Caribbean Group (NYSE:RCL) stock to “a Buy”. The rating was released on April 17, 2024, according to finviz. The research report from Citigroup has resumed the stock to Buy, with a price target set at $127. The stock was initiated by HSBC Securities, who disclosed in a […]
Equitrans Midstream Corporation (NYSE:ETRN) stock is trading -9.77 percent below its 52-week high
Wells Fargo raised the price target for the Equitrans Midstream Corporation (NYSE:ETRN) stock from “an Equal weight” to “an Underweight”. The rating was released on December 14, 2023, according to finviz. The research report from Goldman has resumed the stock to Buy, with a price target set at $11.50. In their research brief published June […]
